关注
Pierluigi Russo
Pierluigi Russo
Italian Medicines Agency - University of Chieti and Italian Medicines Agency
在 aifa.gov.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Brain atrophy and lesion load in a large population of patients with multiple sclerosis
G Tedeschi, L Lavorgna, P Russo, A Prinster, D Dinacci, G Savettieri, ...
Neurology 65 (2), 280-285, 2005
2092005
Predictors of long–term clinical response to interferon beta therapy in relapsing multiple sclerosis
V Tomassini, A Paolillo, P Russo, E Giugni, L Prosperini, C Gasperini, ...
Journal of neurology 253, 287-293, 2006
1432006
Caregiver quality of life in multiple sclerosis: a multicentre Italian study
F Patti, MP Amato, MA Battaglia, M Pitaro, P Russo, C Solaro, M Trojano
Multiple Sclerosis Journal 13 (3), 412-419, 2007
1392007
Risk factors for uncontrolled hypertension in Italy
E Degli Esposti, M Di Martino, A Sturani, P Russo, C Dradi, S Falcinelli, ...
Journal of human hypertension 18 (3), 207-213, 2004
1072004
Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective …
GP Fadini, A Avogaro, L Degli Esposti, P Russo, S Saragoni, S Buda, ...
European heart journal 36 (36), 2454-2462, 2015
1052015
The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA
A Paolillo, MC Piattella, P Pantano, S Di Legge, F Caramia, P Russo, ...
Journal of neurology 251, 432-439, 2004
922004
Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS
V Tomassini, L De Giglio, M Reindl, P Russo, I Pestalozza, P Pantano, ...
Multiple Sclerosis Journal 13 (9), 1086-1094, 2007
862007
Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional health care providers
P Russo, FS Mennini, PD Siviero, G Rasi
Annals of oncology 21 (10), 2081-2087, 2010
842010
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in …
V Gebbia, E Maiello, F Giuliani, N Borsellino, M Caruso, G Di Maggio, ...
Annals of Oncology 18, vi124-vi127, 2007
752007
How aligned are the perspectives of EU regulators and HTA bodies? A comparative analysis of regulatory‐HTA parallel scientific advice
G Tafuri, M Pagnini, J Moseley, M Massari, F Petavy, A Behring, A Catalan, ...
British journal of clinical pharmacology 82 (4), 965-973, 2016
682016
Predictors of quality of life among patients with multiple sclerosis: an Italian cross-sectional study
F Patti, P Russo, A Pappalardo, F Macchia, L Civalleri, A Paolillo, ...
Journal of the neurological sciences 252 (2), 121-129, 2007
662007
Monitoring registries at Italian Medicines Agency: fostering access, guaranteeing sustainability
S Montilla, E Xoxi, P Russo, A Cicchetti, L Pani
International journal of technology assessment in health care 31 (4), 210-213, 2015
602015
Small animal imaging facility: new perspectives for the radiologist
R Grassi, C Cavaliere, S Cozzolino, L Mansi, S Cirillo, G Tedeschi, ...
La radiologia medica 114 (1), 152-167, 2009
502009
Television viewing and personality structure in children
C Persegani, P Russo, C Carucci, M Nicolini, LL Papeschi, M Trimarchi
Personality and individual differences 32 (6), 977-990, 2002
492002
Advanced age and medication prescription: more years, less medications? A nationwide report from the Italian Medicines Agency
G Onder, A Marengoni, P Russo, L Degli Esposti, M Fini, A Monaco, ...
Journal of the American Medical Directors Association 17 (2), 168-172, 2016
452016
Proposta di linee guida per la valutazione economica degli interventi sanitari
G Aguzzi, G Baio, S Capri, M Cavazza, A Cicchetti, C Cislaghi, ...
Politiche sanitarie 10 (2), 83-93, 2009
442009
OsMed Health-DB Network. Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering …
GP Fadini, A Avogaro, L Degli Esposti, P Russo, S Saragoni, S Buda, ...
Eur Heart J 36 (36), 2454-62, 2015
412015
The impact of parallel regulatory–health technology assessment scientific advice on clinical development. Assessing the uptake of regulatory and health technology assessment …
G Tafuri, I Lucas, S Estevão, J Moseley, A d'Andon, H Bruehl, E Gajraj, ...
British Journal of Clinical Pharmacology 84 (5), 1013-1019, 2018
402018
Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis
E Cocco, P Marchi, C Sardu, P Russo, A Paolillo, MG Mascia, M Solla, ...
Multiple Sclerosis Journal 13 (8), 975-980, 2007
392007
The Italian Multiple Sclerosis Database Network (MSDN): the risk of worsening according to IFNβ exposure in multiple sclerosis
M Trojano, P Russo, A Fuiani, D Paolicelli, E Di Monte, E Granieri, ...
Multiple Sclerosis Journal 12 (5), 578-585, 2006
382006
系统目前无法执行此操作,请稍后再试。
文章 1–20